Takamatsu, S.; Morita, C.; Sakon, D.; Nakamura, K.; Hishii, H.; Kondo, J.; Ueda, K.; Miyoshi, E.
Potential for Core Fucose-Targeted Therapy Against HBV Infection of Human Normal Hepatocytes. Viruses 2025, 17, 1242.
https://doi.org/10.3390/v17091242
AMA Style
Takamatsu S, Morita C, Sakon D, Nakamura K, Hishii H, Kondo J, Ueda K, Miyoshi E.
Potential for Core Fucose-Targeted Therapy Against HBV Infection of Human Normal Hepatocytes. Viruses. 2025; 17(9):1242.
https://doi.org/10.3390/v17091242
Chicago/Turabian Style
Takamatsu, Shinji, Chiharu Morita, Daisuke Sakon, Kotaro Nakamura, Honoka Hishii, Jumpei Kondo, Keiji Ueda, and Eiji Miyoshi.
2025. "Potential for Core Fucose-Targeted Therapy Against HBV Infection of Human Normal Hepatocytes" Viruses 17, no. 9: 1242.
https://doi.org/10.3390/v17091242
APA Style
Takamatsu, S., Morita, C., Sakon, D., Nakamura, K., Hishii, H., Kondo, J., Ueda, K., & Miyoshi, E.
(2025). Potential for Core Fucose-Targeted Therapy Against HBV Infection of Human Normal Hepatocytes. Viruses, 17(9), 1242.
https://doi.org/10.3390/v17091242
